Trinity Biotech's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Trinity Biotech (NASDAQ:TRIB) is set to release its latest quarterly earnings report on July 6, 2023. Analysts estimate an earnings per share (EPS) of $-0.06. The company's past performance shows a mixed trend in EPS and price change. The stock was trading at $0.975 as of July 4, and over the last 52-week period, shares are down 29.1%.
July 05, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Trinity Biotech's upcoming earnings report could impact its stock price. The company's shares have been on a downward trend, falling 29.1% over the past 52 weeks.
Trinity Biotech's stock price has been on a downward trend, with shares falling 29.1% over the past 52 weeks. The upcoming earnings report, where analysts estimate an EPS of $-0.06, could further impact the stock price. If the company fails to meet or exceed this estimate, it could lead to a further decline in the stock price. Conversely, if the company beats the estimate and provides positive guidance, it could potentially boost the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100